Novartis and Microsoft have announced a new collaboration with the aim to “transform medicine with artificial intelligence.” Novartis announced the “important step in reimagining medicine” by founding the Novartis AI innovation lab, choosing Microsoft as its strategic AI and data-science partner. The company says that the new lab will look to bolster Novartis AI capabilities
A recent study has shown that an AI ‘deep learning’ system has been found to detect malignant lung nodules on low-dose chest computed tomography (LDCT) scans sooner than radiologists. The study from Google and North-western Medicine compared the deep-learning system against radiologists on LDCTs for patients, some of whom had biopsy confirmed cancer within a
A team led by the Institute of Cancer Research London (ICR) and the University of Edinburgh developed a new technique known as Revolver (Repeated Evolution of Cancer). Which could enable doctors to create the most effective treatment for each patient. The technique picks out patterns in DNA mutation within cancers and then uses the information
UK government has announced a new project to develop the world’s first fully-automated drug discovery facility with the aim to accelerate the production of new medicines and “transform” the pharma industry. Business Secretary, Greg Clark, stated that the venture, which is based at the government-funded research facility the Rosalind Franklin Institute in Harwell, Oxfordshire, will
Theresa May has pledged to prioritise artificial intelligence to aid the diagnosis of chronic diseases at an early stage, which could potentially save many lives. The government is hoping that AI will help to prevent 22,000 cancer deaths each year by 2033 by detecting prostate, ovarian, lung and bowel cancer at a less serious and
Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that has the ability to diagnose patients with breast cancer 97% of the time. The current screening process for breast cancer involves a mammogram and in the event of abnormal cells are identified, a needle biopsy is the next
Insilico Medicine, a biotech based in Baltimore, develops advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing. Many of these molecules aim to induce the expression of certain genes involved in the endogenous repair processes to slow down and even reverse some of the aging-associated diseases. By applying a
